Analysis of computed tomography findings and inflammatory markers in diabetic post COVID patients

ABSTRACT

Objective: To evaluate chest computed tomography (CT) findings and inflammatory markers in diabetic Post COVID patients. Methods: 79 Post COVID-19 patients admitted to our Pulmonary Medicine Ward were included according to the inclusion and exclusion criteria, their HRCT findings and markers of inflammation(ESR,CRP,S.LDH ,S.Ferretin ) were studied. Results: Out of 79,44 patients were diabetic and 35 were non-diabetic. Diabetic patients had more severe radiological involvement as indicated by high CT Severity Index(CTSI) [ W = 1070.000, p = 0.003] and high biochemical markers as indicated by high S.LDH[W = 1164.000, p = <0.001], S.Ferretin[W = 1183.000, p = <0.001], ESR [W = 977.500, p = 0.039] and CRP [W = 1170.000, p = <0.001], as compared to non diabetic patients.re Conclusions: Most COVID-19 survivors still had physiologically relevant CT abnormalities and deranged markers of inflammation and this derangement was more severe in diabetic patients.All these markers levels should be accurately evaluated in the long-term follow-up, with individualised consideration for prophylactic antiinflammatory therapy if indicated.